Combined liver-intestinal and multivisceral transplantation for neuroendocrine tumors extending beyond the liver: A systematic literature review

Oronsky, 2017, Nothing but NET: a review of neuroendocrine tumors and carcinomas, Neoplasia, 19, 991, 10.1016/j.neo.2017.09.002 Nagtegaal, 2020, The 2019 WHO classification of tumours of the digestive system, Histopathology, 76, 182, 10.1111/his.13975 Pavel, 2016, ENETS consensus guidelines update for the Management of Distant Metastatic Disease of intestinal, pancreatic, bronchial neuroendocrine neoplasms (NEN) and NEN of unknown primary site, Neuroendocrinology, 103, 172, 10.1159/000443167 Dasari, 2017, Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States, JAMA Oncol, 3, 1335, 10.1001/jamaoncol.2017.0589 Hemminki, 2001, Incidence trends and risk factors of carcinoid tumors: a nationwide epidemiologic study from Sweden, Cancer, 92, 2204, 10.1002/1097-0142(20011015)92:8<2204::AID-CNCR1564>3.0.CO;2-R Cives, 2018, Gastroenteropancreatic neuroendocrine tumors, CA Cancer J Clin, 68, 471, 10.3322/caac.21493 Gedaly, 2011, Liver transplantation for the treatment of liver metastases from neuroendocrine tumors: an analysis of the UNOS database, Arch Surg, 146, 953, 10.1001/archsurg.2011.186 Le Treut, 2013, Liver transplantation for neuroendocrine tumors in Europe-results and trends in patient selection: a 213-case European liver transplant registry study, Ann Surg, 257, 807, 10.1097/SLA.0b013e31828ee17c Mazzaferro, 2016, The long-term benefit of liver transplantation for hepatic metastases from neuroendocrine tumors, Am J Transplant, 16, 2892, 10.1111/ajt.13831 Ceulemans, 2015, Preoperative arterial embolization facilitates multivisceral transplantation for portomesenteric thrombosis, Am J Transplant, 15, 2963, 10.1111/ajt.13336 Vianna, 2012, Multivisceral transplantation for diffuse portomesenteric thrombosis, Ann Surg, 255, 1144, 10.1097/SLA.0b013e31825429c0 Moon, 2005, Intestinal transplantation for the treatment of neoplastic disease, J Surg Oncol, 92, 284, 10.1002/jso.20416 Mangus, 2013, Multivisceral transplantation: expanding indications and improving outcomes, J Gastrointest Surg, 17, 179, 10.1007/s11605-012-2047-7 Nikeghbalian, 2013, Multivisceral transplantation for the treatment of intra-abdominal tumors, Transplant Proc, 45, 3528, 10.1016/j.transproceed.2013.09.002 Engberg, 2008, Systematic reviews and meta-analysis: studies of studies, J Wound Ostomy Continence Nurs, 35, 258, 10.1097/01.WON.0000319122.76112.23 Ceulemans, 2016, Systematic literature review on self-reported quality of life in adult intestinal transplantation, Transplant Rev (Orlando), 30, 109, 10.1016/j.trre.2016.02.004 PROSPERO PRISMA guidelines Calil, 2015, The multivisceral transplant program at university of São Paulo medical school-Brazil, Transplantation, 99, S97 Clift, 2017, Neoadjuvant peptide receptor radionuclide therapy and modified multivisceral transplantation for an advanced small intestinal neuroendocrine neoplasm: an updated case report, Innov Surg Sci, 2, 247 Galvao, 2019, Intestinal and multivisceral transplantation at hospital dasclinicas da faculdade De medicina da universidade De Sao Paulo (HC-FMUSP)-Brazil, Neurology, 92 Kornberg, 2001, Multivisceral transplantation for abdominal malignancy: indication, technique, and results in three patients, Transplant Proc, 33, 1558, 10.1016/S0041-1345(00)02593-8 Mangus, 2014, Multivisceral transplantation for non-resectable abdominal neuroendocrine tumors, Gastroenterology, 146, S, 10.1016/S0016-5085(14)63759-8 Olausson, 2007, Orthotopic liver or multivisceral transplantation as treatment of metastatic neuroendocrine tumors, Liver Transpl, 13, 327, 10.1002/lt.21056 Rao, 2016, Use of Everolimus after multivisceral transplantation: a report of two cases, Transplant Proc, 48, 485, 10.1016/j.transproceed.2015.11.034 Sher, 2015, Liver transplantation for metastatic neuroendocrine tumors: outcomes and prognostic variables, J Surg Oncol, 112, 125, 10.1002/jso.23973 Todo, 1995, Abdominal multivisceral transplantation, Transplantation., 59, 234, 10.1097/00007890-199501270-00015 Varkey, 2015, Fifteen years’ experience of intestinal and multivisceral transplantation in the Nordic countries, Scand J Gastroenterol, 50, 278, 10.3109/00365521.2014.999255 Frilling, 2006, Liver transplantation for patients with metastatic endocrine tumors: single-center experience with 15 patients, Liver Transpl, 12, 1089, 10.1002/lt.20755 Sposito, 2017, The place of liver transplantation in the treatment of hepatic metastases from neuroendocrine tumors: pros and cons, Rev Endocr Metab Disord, 18, 473, 10.1007/s11154-017-9439-7 Rosenau, 2002, Ki67, E-cadherin, and p53 as prognostic indicators of long-term outcome after liver transplantation for metastatic neuroendocrine tumors, Transplantation, 73, 386, 10.1097/00007890-200202150-00012 Butler, 2017, Use of arterial embolisation to facilitate Exenteration during multivisceral and small bowel transplantation, Transplantation, 101, S25 Walter, 2019, Everolimus after hepatic arterial embolisation therapy of metastases from gastrointestinal neuroendocrine tumours: the FFCD 1104-EVACEL-GTE phase II study, Eur J Cancer, 123, 92, 10.1016/j.ejca.2019.09.021 Moris, 2017, Liver transplantation in patients with liver metastases from neuroendocrine tumors: a systematic review, Surgery., 162, 525, 10.1016/j.surg.2017.05.006 Frilling, 2015, Therapeutic strategies for neuroendocrine liver metastases, Cancer., 121, 1172, 10.1002/cncr.28760 International Intestinal Transplantation Registry (ITR) Rossi, 2014, Liver transplantation for unresectable neuroendocrine tumor liver metastases, Ann Surg Oncol, 21, 2398, 10.1245/s10434-014-3523-y De Simone, 2012, Everolimus with reduced tacrolimus improves renal function in de novo liver transplant recipients: a randomized controlled trial, Am J Transplant, 12, 3008, 10.1111/j.1600-6143.2012.04212.x Yao, 2016, Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study, Lancet, 968, 10.1016/S0140-6736(15)00817-X De Simone, 2017, Use of Everolimus in liver transplantation: recommendations from a working group, Transplantation., 101, 239, 10.1097/TP.0000000000001438